{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T04:17:31Z","timestamp":1729657051803,"version":"3.28.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,22]]},"DOI":"10.7759\/cureus.72093","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T08:43:24Z","timestamp":1729586604000},"source":"Crossref","is-referenced-by-count":0,"title":["Cancer Patients' Views on Ultrahypofractionated Radiotherapy: A Questionnaire-Based Survey"],"prefix":"10.7759","author":[{"given":"Koyo","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirobumi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Ieko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanori","family":"Ariga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2018.08.002","article-title":"Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline","volume":"8","author":"Morgan SC","year":"2018","unstructured":"Morgan SC, Hoffman K, Loblaw DA, et al.. Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline. Pract Radiat Oncol. 2018, 8:354-60. 10.1016\/j.prro.2018.08.002","journal-title":"Pract Radiat Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02750","article-title":"Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer","volume":"38","author":"Brunt AM","year":"2020","unstructured":"Brunt AM, Haviland JS, Sydenham M, et al.. Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer. J Clin Oncol. 2020, 38:3261-72. 10.1200\/JCO.19.02750","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt A","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, et al.. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020, 395:1613-26. 10.1016\/S0140-6736(20)30932-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92307-8","article-title":"Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients","volume":"11","author":"Ishiyama H","year":"2021","unstructured":"Ishiyama H, Tsumura H, Nagano H, et al.. Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients. Sci Rep. 2021, 11:13194. 10.1038\/s41598-021-92307-8","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree AC","year":"2022","unstructured":"Tree AC, Ostler P, van der Voet H, et al.. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2022, 23:1308-20. 10.1016\/S1470-2045(22)00517-4","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.03.057","article-title":"Every-other-day versus once-a-week urethra-sparing prostate stereotactic body radiation therapy: 5-year results of a randomized phase 2 trial","volume":"117","author":"Zilli T","year":"2023","unstructured":"Zilli T, Jorcano S, Bral S, et al.. Every-other-day versus once-a-week urethra-sparing prostate stereotactic body radiation therapy: 5-year results of a randomized phase 2 trial. Int J Radiat Oncol Biol Phys. 2023, 117:791-8. 10.1016\/j.ijrobp.2023.03.057","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2018.06.005","article-title":"Effect of daily and every other day stereotactic body radiation therapy schedules on treatment-related fatigue in patients with hepatocellular carcinoma","volume":"9","author":"Hasan S","year":"2019","unstructured":"Hasan S, Renz P, Packard M, Horrigan S, Gresswell S, Kirichenko AV. Effect of daily and every other day stereotactic body radiation therapy schedules on treatment-related fatigue in patients with hepatocellular carcinoma. Pract Radiat Oncol. 2019, 9:e38-45. 10.1016\/j.prro.2018.06.005","journal-title":"Pract Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2018.04.004","article-title":"Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule","volume":"8","author":"Samson P","year":"2018","unstructured":"Samson P, Rehman S, Juloori A, et al.. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule. Pract Radiat Oncol. 2018, 8:404-13. 10.1016\/j.prro.2018.04.004","journal-title":"Pract Radiat Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.0362","article-title":"Quality-of-life outcomes and toxic effects among patients with cancers of the uterus treated with stereotactic pelvic adjuvant radiation therapy: the SPARTACUS phase 1\/2 nonrandomized controlled trial","volume":"8","author":"Leung E","year":"2022","unstructured":"Leung E, Gladwish AP, Davidson M, et al.. Quality-of-life outcomes and toxic effects among patients with cancers of the uterus treated with stereotactic pelvic adjuvant radiation therapy: the SPARTACUS phase 1\/2 nonrandomized controlled trial. JAMA Oncol. 2022, 8:1-9. 10.1001\/jamaoncol.2022.0362","journal-title":"JAMA Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140646","article-title":"0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers","volume":"88","author":"Nguyen NT","year":"2015","unstructured":"Nguyen NT, Doerwald-Munoz L, Zhang H, Kim DH, Sagar S, Wright JR, Hodson DI. 0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers. Br J Radiol. 2015, 88:20140646. 10.1259\/bjr.20140646","journal-title":"Br J Radiol"},{"key":"ref11","unstructured":"JASTRO Japanese Radiation Oncology Database 2022 (in Japanese). (2022). Accessed. 8\/6\/2024: https:\/\/www.jastro.or.jp\/medicalpersonnel\/data_center\/JROD2022.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110092","article-title":"The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: a national population-based evaluation","volume":"192","author":"Han L","year":"2024","unstructured":"Han L, Sullivan R, Tree A, et al.. The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: a national population-based evaluation. Radiother Oncol. 2024, 192:110092. 10.1016\/j.radonc.2024.110092","journal-title":"Radiother Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2196\/12781","article-title":"Physician decision-making patterns and family presence: cross-sectional online survey study in Japan","volume":"8","author":"Tsuda K","year":"2019","unstructured":"Tsuda K, Higuchi A, Yokoyama E, Kosugi K, Komatsu T, Kami M, Tanimoto T. Physician decision-making patterns and family presence: cross-sectional online survey study in Japan. Interact J Med Res. 2019, 8:e12781. 10.2196\/12781","journal-title":"Interact J Med Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2016.09.012","article-title":"Focusing on the \u201cperson\u201d in personalized medicine: the future of patient-centered care in radiation oncology","volume":"13","author":"Berman AT","year":"2016","unstructured":"Berman AT, Rosenthal SA, Moghanaki D, Woodhouse KD, Movsas B, Vapiwala N. Focusing on the \u201cperson\u201d in personalized medicine: the future of patient-centered care in radiation oncology. J Am Coll Radiol. 2016, 13:1571-8. 10.1016\/j.jacr.2016.09.012","journal-title":"J Am Coll Radiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.12450","article-title":"Japan as the front-runner of super-aged societies: perspectives from medicine and medical care in Japan","volume":"15","author":"Arai H","year":"2015","unstructured":"Arai H, Ouchi Y, Toba K, et al.. Japan as the front-runner of super-aged societies: perspectives from medicine and medical care in Japan. Geriatr Gerontol Int. 2015, 15:673-87. 10.1111\/ggi.12450","journal-title":"Geriatr Gerontol Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14201","article-title":"Toward the development of a vibrant, super-aged society: the future of medicine and society in Japan","volume":"21","author":"Iijima K","year":"2021","unstructured":"Iijima K, Arai H, Akishita M, et al.. Toward the development of a vibrant, super-aged society: the future of medicine and society in Japan. Geriatr Gerontol Int. 2021, 21:601-13. 10.1111\/ggi.14201","journal-title":"Geriatr Gerontol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2019.12.028","article-title":"Choosing between conventional and hypofractionated prostate cancer radiation therapy: results from a study of shared decision-making","volume":"25","author":"Shakespeare TP","year":"2020","unstructured":"Shakespeare TP, Westhuyzen J, Lim Yew Fai T, Aherne NJ. Choosing between conventional and hypofractionated prostate cancer radiation therapy: results from a study of shared decision-making. Rep Pract Oncol Radiother. 2020, 25:193-9. 10.1016\/j.rpor.2019.12.028","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.06.054","article-title":"Radiation fractionation schedules published during the COVID-19 pandemic: a systematic review of the quality of evidence and recommendations for future development","volume":"108","author":"Thomson DJ","year":"2020","unstructured":"Thomson DJ, Yom SS, Saeed H, et al.. Radiation fractionation schedules published during the COVID-19 pandemic: a systematic review of the quality of evidence and recommendations for future development. Int J Radiat Oncol Biol Phys. 2020, 108:379-89. 10.1016\/j.ijrobp.2020.06.054","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275206-cancer-patients-views-on-ultrahypofractionated-radiotherapy-a-questionnaire-based-survey","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T08:43:27Z","timestamp":1729586607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275206-cancer-patients-views-on-ultrahypofractionated-radiotherapy-a-questionnaire-based-survey"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.72093","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,22]]}}}